TJ
Trigilio Jeffrey
首席财务官
OtherM
内部人交易记录
首席财务官尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Browse the detailed record of transactions filed by Trigilio Jeffrey, 首席财务官. Insider active across 2 companies, notably Cullinan Oncology, Inc.. Cumulatively, 23 filings have been recorded. Breakdown: 0 buy · 10 sells. Total volume traded: €58k. History available since 8 September 2021. The latest transaction was disclosed on 20 April 2026 (Levée d'options). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Trigilio Jeffrey
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
申报23 总计
103,906 股Common StockSEC:0001193125-26-303720:0
11,538 股0Common StockSEC:0001214659-26-004971:0
4,000 股0Common StockSEC:0001214659-26-004709:0
1,632 股@ US$36.76100.0% 占其流量Common StockSEC:0001214659-26-004709:1
90,000 股0Common StockSEC:0001214659-26-003284:0
50,000 股0Common StockSEC:0000950170-24-019458:0
1,920 股@ US$8.505.7% 占其流量Common StockSEC:0000950170-23-072754:0
398 股@ US$8.221.1% 占其流量Common StockSEC:0000950170-23-071985:0
1,926 股@ US$7.815.3% 占其流量Common StockSEC:0000950170-23-070143:0
2,340 股@ US$9.087.4% 占其流量Common StockSEC:0000950170-23-031858:0
399 股@ US$12.941.8% 占其流量Common StockSEC:0000950170-23-029158:0
319 股@ US$13.111.5% 占其流量Common StockSEC:0000950170-23-027985:0
399 股@ US$8.761.2% 占其流量Common StockSEC:0000899243-23-013358:0
347 股@ US$8.781.1% 占其流量Common StockSEC:0000950170-23-022548:0
398 股@ US$10.711.5% 占其流量Common StockSEC:0000950170-23-013702:0
318 股@ US$10.221.1% 占其流量Common StockSEC:0000899243-23-011298:0
399 股@ US$11.321.6% 占其流量Common StockSEC:0000899243-23-009718:0
47,000 股0Common StockSEC:0000899243-23-005736:0
201 股@ US$8.970.6% 占其流量Common StockSEC:0000899243-23-001157:0
1,451 股@ US$10.905.8% 占其流量Common StockSEC:0000899243-22-025080:0
37,500 股0Common StockSEC:0000899243-22-006412:0
8,000 股@ US$4.3016.7% 占其流量Common StockSEC:0000899243-21-040454:0
15,000 股@ US$4.3030.6% 占其流量Common StockSEC:0000899243-21-035417:0
About Trigilio Jeffrey
Trigilio Jeffrey is Chief Financial Officer at Cullinan Oncology, Inc. and XOMA Royalty Corp. He has 23 filings in total, and across the sampled recent filings from 2021-09-09 to 2026-07-14, the amounts are only sales, totaling EUR 57601.